Follow-up duration (year) | TN and psychiatric illness | Control cohort | Risk ratio (95Â % CI) | ||
---|---|---|---|---|---|
No. of Depressive disorder | Per 1000 person-years | No. of Depressive disorder | Per 1000 person-years | ||
Overall | 73 | 2.76 | 103 | 0.82 | 2.86 (2.09–3.90)a |
0–1 | 32 | 9.85 | 24 | 1.84 | 5.36 (3.06–9.51)a |
≥1 | 41 | 3.93 | 79 | 1.94 | 2.02 (1.33–3.02)a |
Follow-up duration (year) | TN and psychiatric illness | Control cohort | Risk ratio (95Â % CI) | ||
No. of Anxiety disorder | Per 1000 person-years | No. of Anxiety disorder | Per 1000 person-years | ||
Overall | 59 | 2.57 | 79 | 0.85 | 3.01 (2.11–4.27)a |
0–1 | 20 | 6.14 | 20 | 1.53 | 4.01 (2.05–7.86)a |
≥1 | 39 | 4.02 | 59 | 1.46 | 2.76 (1.79–4.22)a |
Follow-up duration (year) | TN and psychiatric illness | Control cohort | Risk ratio (95Â % CI) | ||
No. of sleep disorder | Per 1000 person-years | No. of sleep disorder | Per 1000 person-years | ||
Overall | 40 | 1.74 | 74 | 0.80 | 2.17 (1.44–3.24)a |
0–1 | 12 | 3.68 | 20 | 1.53 | 2.40 (1.07–5.16)a |
≥1 | 28 | 2.88 | 54 | 1.38 | 2.09 (1.27–3.35)a |